Triasima Portfolio Management inc. Reduces Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Triasima Portfolio Management inc. reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 0.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,567 shares of the biotechnology company’s stock after selling 52 shares during the quarter. Triasima Portfolio Management inc.’s holdings in Axon Enterprise were worth $2,227,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AXON. Vanguard Group Inc. grew its position in shares of Axon Enterprise by 2.7% in the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after purchasing an additional 212,401 shares in the last quarter. Sands Capital Management LLC boosted its stake in Axon Enterprise by 0.6% during the fourth quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock worth $679,060,000 after buying an additional 16,347 shares during the last quarter. Norges Bank purchased a new stake in Axon Enterprise in the 4th quarter valued at $195,406,000. Westfield Capital Management Co. LP increased its stake in shares of Axon Enterprise by 5.1% in the 4th quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock worth $189,025,000 after acquiring an additional 35,528 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Axon Enterprise by 2.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 580,757 shares of the biotechnology company’s stock worth $150,027,000 after acquiring an additional 15,840 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. JMP Securities reissued a “market outperform” rating and issued a $375.00 price objective on shares of Axon Enterprise in a report on Wednesday, August 7th. Needham & Company LLC reissued a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday, August 7th. Jefferies Financial Group assumed coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target on the stock. Barclays upped their price objective on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Finally, Craig Hallum raised their target price on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $358.08.

Axon Enterprise Trading Down 0.1 %

AXON traded down $0.24 during mid-day trading on Friday, hitting $354.62. 509,150 shares of the stock were exchanged, compared to its average volume of 514,277. The firm’s fifty day moving average is $331.40 and its two-hundred day moving average is $311.15. Axon Enterprise, Inc. has a 1-year low of $189.12 and a 1-year high of $378.89. The company has a market cap of $26.76 billion, a PE ratio of 103.69, a PEG ratio of 9.52 and a beta of 0.94. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million for the quarter, compared to analysts’ expectations of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business’s quarterly revenue was up 34.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.80 earnings per share. Equities analysts forecast that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In related news, Director Matthew R. Mcbrady sold 2,000 shares of the business’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the transaction, the director now directly owns 4,892 shares of the company’s stock, valued at approximately $1,783,916.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Axon Enterprise news, Director Julie A. Cullivan sold 900 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the transaction, the director now owns 3,653 shares in the company, valued at approximately $1,291,445.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Matthew R. Mcbrady sold 2,000 shares of the firm’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the sale, the director now owns 4,892 shares in the company, valued at $1,783,916.72. The disclosure for this sale can be found here. Insiders sold 278,650 shares of company stock valued at $101,364,745 in the last 90 days. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.